Dérivés de Quinazoline et de Quinoléine
Les quinazolines et les quinoléines sont des composés hétérocycliques azotés à structure aromatique qui jouent un rôle clé dans la synthèse de médicaments à activité anticancéreuse, antimicrobienne et anti-inflammatoire. Leurs dérivés présentent des modifications structurelles qui optimisent leur biodisponibilité et leur sélectivité, permettant ainsi le développement de nouveaux principes actifs pour diverses applications thérapeutiques. Ces composés sont utilisés dans la fabrication d’API destinés au traitement du cancer, des infections, des maladies neurodégénératives et cardiovasculaires. De plus, les dérivés de quinazoline et de quinoléine sont essentiels dans la recherche d’inhibiteurs enzymatiques et dans la conception de molécules bioactives innovantes.
Chez CymitQuimica, nous proposons des dérivés de quinazoline et de quinoléine de haute pureté pour des applications en synthèse chimique, développement pharmaceutique et biotechnologie.
65576 produits trouvés pour "Dérivés de Quinazoline et de Quinoléine"
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
Carbomer Homopolymer
CAS :Other acrylic polymers in primary forms (excluding elastomeric)Couleur et forme :White Powder5-Methylisoxazole-4-carboxylic Acid (5-Methyl-1,2-oxazole-4-carboxylic acid)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C5H5NO3Couleur et forme :White SolidMasse moléculaire :127.026944-Methylacetophenone (1-(4-Methylphenyl)-1-ethanone (4'-Methylacetophenone))
CAS :Aromatic ketones without other oxygen function, nesoiFormule :C9H10OCouleur et forme :Colorless LiquidMasse moléculaire :134.07316Dabigatran Etexilate Mesylate
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C34H41N7O5·CH4O3SCouleur et forme :White Off-White Yellow PowderMasse moléculaire :723.30503Dabigatran Etexilate Related Compound C (Ethyl 3-(2-{[(4-{N'-[(2-ethylbutoxy)carbonyl]carbamimidoyl}phenyl)amino]methyl}-1-methyl-N-(pyridin-2-yl)-1H-benzimidazole-5-carboxamido)propanoate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C34H41N7O5Couleur et forme :PowderMasse moléculaire :627.31692Metoprolol Related Compound D ((+/-)N,N-bis-[2-hydroxy-3-[4-(2-methoxyethyl)phenoxy]propyl](1-methylethyl)amine hydrochloride)
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C27H41NO6·HClCouleur et forme :White PowderMasse moléculaire :475.29339Anastrozole
CAS :Aromatic or modified aromatic drugs with nitrogen heterFormule :C17H19N5Couleur et forme :Off-White PowderMasse moléculaire :293.16405Diphthalimido Morpholinone Analog (2,2'-((2R,2'R)-((4-(3-oxomorpholino)phenyl)azanediyl)bis(2-hydroxypropane-3,1-diyl))bis(isoindoline-1,3-dione))
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C32H30N4O8Couleur et forme :Pale Yellow SolidMasse moléculaire :598.20636Clioquinol
CAS :Drugs containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) not further fusedFormule :C9H5ClINOCouleur et forme :PowderMasse moléculaire :304.91044Aripiprazole Related Compound F (4-(2,3-dichlorophenyl)-1-[4-(2-oxo-1,2,3,4-tetrahydroquinolin-7-yloxy)butyl]piperazin 1-oxide)
CAS :Lactams not elsewhere specified or includedFormule :C23H27Cl2N3O3Couleur et forme :White Light Yellow PowderMasse moléculaire :464.39Anastrozole Diacid (2,2'-(5-((1H-1,2,4-triazol-1-yl)methyl)-1,3-phenylene)bis(2-methylpropanoic acid))
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C17H21N3O4Couleur et forme :Off-White SolidMasse moléculaire :331.15321Paliperidone Resolution Mixture
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiCouleur et forme :White PowderDofetilide
CAS :Sulfonamides used as drugsFormule :C19H27N3O5S2Couleur et forme :White Off-White Crystalline PowderMasse moléculaire :441.13921Fluphenazine Decanoate Dihydrochloride
CAS :Antidepressants, tranquilizers and other pschotherapeutic agentsFormule :C32H44F3N3O2S·2HClCouleur et forme :White PowderMasse moléculaire :663.26399Metoprolol Related Compound E (3-[4-(2-Methoxyethyl)phenoxy]propane-1,2-diol)
CAS :Ether-alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives not elsewhere specified or includedFormule :C12H18O4Couleur et forme :White Coarse Powder Semi-SolidMasse moléculaire :226.12051Rivaroxaban Related Compound D (1,3-Bis({(S)-2-oxo-3-[4-(3-oxomorpholino)phenyl]oxazolidin-5-yl}methyl)urea)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C29H32N6O9Couleur et forme :Off-White White SolidMasse moléculaire :608.22308Paroxetine Methoxy (3R,4S)-Enantiomer Hydrochloride ((3R,4S)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-methoxyphenyl)piperidine, hydrochloride)
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C20H23NO4·HClCouleur et forme :White Off-White SolidMasse moléculaire :341.16271Rotigotine Racemate ((RS)-6-{Propyl[2-(thiophen-2-yl)ethyl]amino}-5,6,7,8-tetrahydronaphthalen-1-ol hydrochloride)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C19H25NOSCouleur et forme :Off-White CrystalsMasse moléculaire :315.16569Amiodarone Hydrochloride
CAS :Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormule :C25H29I2NO3·HClCouleur et forme :White PowderMasse moléculaire :681.78 g/mol1,4-Sorbitan
CAS :Compounds containing an unfused furan ring (whether or not hydrogenated) in the structure nesoiFormule :C6H12O5Couleur et forme :White Crystalline PowderMasse moléculaire :164.06847R,R,S-Ezetimibe ((3R,4S)-1-(4-fluorophenyl)-3-((R)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one)
CAS :Lactams not elsewhere specified or includedFormule :C24H21F2NO3Couleur et forme :White Off-White SolidMasse moléculaire :409.14895Dichlorothienoic Acid (4,5-dichlorothiophene-2-carboxylic acid)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C5H2Cl2O2SCouleur et forme :Off-White SolidMasse moléculaire :195.91526Hexyl Methanesulfonate
CAS :Hydrocarbon derivatives containing only sulfo groups, their salts andestersFormule :C7H16O3SCouleur et forme :Clear Yellow LiquidMasse moléculaire :180.08202Anastrozole Nitrile Acid (2-{3-[(1H-1,2,4-Triazol-1-yl)methyl]-5-(2-cyanopropan-2-yl)phenyl}-2-methylpropanoic acid)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C17H20N4O2Couleur et forme :White PowderMasse moléculaire :312.15863Nilotinib Related Compound B (Methyl 3-amino-4-methylbenzoate)
CAS :Aromatic amino-acids and their esters, other than those containing more than one kind of oxygen function, nesoiFormule :C9H11NO2Couleur et forme :Off-White Light Yellow PowderMasse moléculaire :165.07898Norepinephrine Bitartrate
CAS :Catecholamine hormones (excluding epinephrine), their derivatives and structural analoguesFormule :C8H11NO3·C4H6O6·H2OCouleur et forme :White Light Grey Crystalline PowderMasse moléculaire :337.1009Tazarotene Related Compound B (Ethyl 6-chloronicotinate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C8H8ClNO2Couleur et forme :Colorless Material Melts At 30⁰ C And Becomes Liquid However The Material Is In Solid State At Below 25⁰CMasse moléculaire :185.02436Apixaban Related Compound D (N-Formyl-1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide)
CAS :Lactams, nesoiFormule :C26H25N5O5Couleur et forme :White Off-White PowderMasse moléculaire :487.18557Metoprolol Related Compound B ((+/-)1-Chloro-2-hydroxy-3-[4-(2-methoxyethyl)phenoxy]-propane)
CAS :Ether-alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives not elsewhere specified or includedFormule :C12H17ClO3Couleur et forme :Pale Yellow Clear LiquidMasse moléculaire :244.086625-Hydroxymethylfurfural (5-(Hydroxymethyl)-2-furaldehyde)
CAS :Compounds containing an unfused furan ring, whether or not hydrogenated, in the structure, nesoiFormule :C6H6O3Couleur et forme :Yellow SolidMasse moléculaire :126.03169Bicalutamide
CAS :Other aromatic organo-sulfur compounds (excluding pesticides)Formule :C18H14F4N2O4SCouleur et forme :White Off-White PowderMasse moléculaire :430.06104Metoprolol Related Compound C (4-[2-Hydroxy-3-(isopropylamino)propoxy]benzaldehyde hydrochloride)
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C13H19NO3·HClCouleur et forme :White PowderMasse moléculaire :237.13649Sorbitol
CAS :D-glucitol (sorbitol)Formule :C6H14O6Couleur et forme :White Crystalline PowderMasse moléculaire :182.17 g/molAminoethyl Fluvoxamine Dihydrochloride ((E)-5-Methoxy-1-[4-(trifluoromethyl)phenyl]pentan-1-one O-{2-[(2-aminoethyl)amino]ethyl}oxime dihydrochloride)
CAS :Aromatic organic derivatives of hydrazine or of hydroxylamineFormule :C17H26F3N3O2·2HClCouleur et forme :White PowderMasse moléculaire :433.15107Salmeterol Related Compound B (4-{1-Hydroxy-2-[6-(4-phenylbutan-2-yloxy)hexylamino]ethyl}-2-
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C25H37NO4Couleur et forme :Off-White Crystalline PowderMasse moléculaire :415.272264-Phenylbutyl(benzyl)amine hydrochloride (N-benzyl-4-phenylbutan-1-amine, hydrochloride)
CAS :Aromatic monoamines and their derivatives, salts thereof, nesoiFormule :C17H21N·HClCouleur et forme :White Off-White SolidMasse moléculaire :239.1674Fluphenazine Hydrochloride
CAS :Antidepressants, tranquilizers and other pschotherapeutic agentsFormule :C22H26F3N3OS·2ClHCouleur et forme :White Off-White Crystalline PowderMasse moléculaire :509.12822Omeprazole Related Compound I (4-Methoxy-2-[[(5-methoxy-1H-benzimidazol-2-yl)sulfonyl]methyl]-3,5-dimethylpyridine 1-oxide)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C17H19N3O5SCouleur et forme :Light Brown Light Orange PowderMasse moléculaire :377.10454Ambrisentan Related Compound C (2-[(4,6-Dimethylpyrimidin-2-yl)oxy]-3-hydroxy-3,3-diphenylpropanoic acid)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C21H20N2O4Couleur et forme :White Off-White SolidMasse moléculaire :364.14231Rotigotine Related Compound C ((S)-6-{[2-(Thiophen-2-yl)ethyl]amino}-5,6,7,8-tetrahydronaphthalen-1-ol hydrochloride)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C16H19NOS·HClCouleur et forme :Light Grey SolidMasse moléculaire :309.09541Apixaban Related Compound H (Ethyl 6-[4-(5-chloropentanamido)phenyl]-1-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate)
CAS :Lactams, nesoiFormule :C27H29ClN4O5Couleur et forme :Off-White PowderMasse moléculaire :524.18265Clozapine Benzoyl Methylpiperazine Analog (1-[2-[(2-Amino-4-chlorophenyl)amino]benzoyl]-4-methylpiperazine)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C18H21ClN4OCouleur et forme :Beige PowderMasse moléculaire :344.14039Apixaban Related Compound E (Methyl 1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate)
CAS :Lactams, nesoiFormule :C26H26N4O5Couleur et forme :Off-White Light Brown Cream PowderMasse moléculaire :474.19032Celecoxib Related Compound A (4-[5-(3-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide)
CAS :Sulfonamides, nesoiFormule :C17H14F3N3O2SCouleur et forme :White PowderMasse moléculaire :381.07588Nadolol Related Compound G (1-(tert-Butylamino)-3-(5,6,7,8-tetrahydronaphthalen-1-yloxy)propan-2-ol)
CAS :Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts therof, nesoiFormule :C17H27NO2Couleur et forme :Off-White PowderMasse moléculaire :277.20418Ambrisentan Related Compound A (4,6-Dimethyl-2-(methylsulfonyl)pyrimidine)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C7H10N2O2SCouleur et forme :Off-White Light Brown Crystalline PowderMasse moléculaire :186.0463Omeprazole Related Compound C (5-Methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylthio]-1H-benzimidazole)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C17H19N3O2SCouleur et forme :White Off-White PowderMasse moléculaire :329.1198Carvedilol Related Compound B (3,3'-(2-(2-methoxyphenoxy)ethylazanediyl)bis(1-(9H-carbazol-4-yloxy)propan-2-ol))
CAS :Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFormule :C39H39N3O6Couleur et forme :Off-White PowderMasse moléculaire :645.283892-Pyridineethanol (2-(Pyridin-2-yl)ethanol)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C7H9NOCouleur et forme :Brown LiquidMasse moléculaire :123.06841Aripiprazole Acid Analog (4-((2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)oxy)butanoic acid)
CAS :Lactams, nesoiFormule :C13H15NO4Couleur et forme :White Off-White SolidMasse moléculaire :249.10011Fluvoxketone (5-Methoxy-1-(4-(trifluoromethyl)phenyl)pentan-1-one)
CAS :Ketones and quinones, w/not with other oxygen function,and their halogenated,sulfated,nitrated,or nitrosated derivatives, nesoiFormule :C13H15F3O2Couleur et forme :White PowderMasse moléculaire :260.10241Regorafenib
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C21H15ClF4N4O3·H2OCouleur et forme :White Brown PowderMasse moléculaire :500.08745Salmeterol Xinafoate
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-pheFormule :C25H37NO4·C11H8O3Couleur et forme :White PowderMasse moléculaire :415.27226Saxagliptin Related Compound C ((1aS,4S,6aR,7aS)-4-[(1r,3R,5R,7S)-3-Hydroxyadamantan-1-yl]hexahydro-1H-cyclopropa[4,5]pyrrolo[1,2-a]pyrazine-3,6-dione)
CAS :Lactams, nesoiFormule :C18H24N2O3Couleur et forme :White PowderMasse moléculaire :316.17869Carvedilol Related Compound C (1-(9H-Carbazol-4-yloxy)-3-(benzyl(2-(2-methoxyphenoxy)ethyl)amino)propan-2-ol)
CAS :Aromatic or modified aromatic drugs with nitrogen hetero-atom(s) only, not elsewhere specified or includedFormule :C31H32N2O4Couleur et forme :Off-White PowderMasse moléculaire :496.23621Clioquinol Related Compound A (5-Chloroquinolin-8-ol)
CAS :Compounds containing a quinoline or isoquinoline ring-system, whether or not hydrogenated, not further fused, excluding drugs and pesticidesFormule :C9H6ClNOCouleur et forme :Off-White PowderMasse moléculaire :179.01379Carvedilol Related Compound A (1-(4-(2-hydroxy-3-(2-(2-methoxyphenoxy)ethylamino)propoxy)-9H-carbazol-9-yl)-3-(2-(2-methoxyphenoxy)ethylamino)propan-2-ol)
CAS :Aromatic or modified aromatic drugs with nitrogen heterFormule :C36H43N3O7Couleur et forme :PowderMasse moléculaire :629.3101Tazarotene
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C21H21NO2SCouleur et forme :White Yellow Crystalline PowderMasse moléculaire :351.1293Refined Bleached Shellac
CAS :Natural gums, gum resins, resins and balsams nesoiCouleur et forme :PowderParticle Count Set (2 blanks (28 mL each) and 2 suspensions (25 mL each))
Polystyrene,nesoiCouleur et forme :Clear Milky Liquid SuspensionAtazanavir S,S,S,R-diastereomer (methyl [(5S,10S,11S,14R)-11-benzyl-5-tert-butyl-10-hydroxy-15,15-dimethyl-3,6,13-trioxo-8-[[4-(pyridin-2-yl)phenyl]methyl]-2-oxa-4,7,8,12-tetraazahexadecan-14-yl]carbamate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C38H52N6O7Couleur et forme :Pale Yellow SolidMasse moléculaire :704.38975Naproxen Related Compound E ((S)-Methyl 2-(6-methoxynaphthalen-2-yl)propanoate)
CAS :Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc, nesoiFormule :C15H16O3Couleur et forme :White Crystalline PowderMasse moléculaire :244.10994Naproxen Sodium
CAS :Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc, nesoiFormule :C14H13NaO3Couleur et forme :White Cream PowderMasse moléculaire :252.07624Argatroban Related Compound C ((2R,4R)-1-[N^8-amino- N^2-(3-methyl-1,2,3,4-tetrahydroquinoline-8-sulfonyl)-L-arginyl]-4-methylpiperidine-2-carboxylic acid)
Sulfonamides, excluding drugsFormule :C23H37N7O5SCouleur et forme :Off-White PowderMasse moléculaire :523.25769Atazanavir Formyl Analog (methyl ((S)-1-(((2S,3S)-4-(2-((S)-2-formamido-3,3-dimethylbutanoyl)-1-(4-(pyridin-2-yl)benzyl)hydrazinyl)-3-hydroxy-1-phenylbutan-2-yl)amino)-3,3-dimethyl-1-oxobutan-2-yl)carbamate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C37H50N6O6Couleur et forme :Off-White SolidMasse moléculaire :674.37918Leflunomide Related Compound A (4-(trifluoromethyl)aniline)
CAS :Toluidines (aminotoluenes) and their derivatives, salts thereofFormule :C7H6F3NCouleur et forme :White Light Yellow LiquidMasse moléculaire :161.04523Methylparaben
CAS :Carboxylic acids with phenol function but without otherFormule :C8H8O3Couleur et forme :White Crystalline PowderMasse moléculaire :152.15Fluvoxamine Maleamide (13-oxo-7-(4-(trifluoromethyl)phenyl)-2,9-dioxa-8,12-diazahexadeca-7,14-dien-16-oic acid)
CAS :Aromatic organic derivatives of hydrazine or of hydroxylamineFormule :C19H23F3N2O5Couleur et forme :Off-White SolidMasse moléculaire :416.15591Rivaroxaban Open Ring Methylamine ((S)-4-(4-((2-hydroxy-3-(methylamino)propyl)amino)phenyl)morpholin-3-one)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C14H21N3O3Couleur et forme :White Off-White SolidMasse moléculaire :279.15829Aripiprazole Spiro Analog (8-(2,3-dichlorophenyl)-5,8-diazaspiro[4.5]decan-5-ium, bromide)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C14H19Cl2N2·BrCouleur et forme :White Off-White SolidMasse moléculaire :285.09253Paroxetine Related Compound C ((3R,4S)-3-[(Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride) OR ((+)-trans-Paroxetine hydrochloride)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C19H20FNO3·HClCouleur et forme :White PowderMasse moléculaire :365.1194Everolimus
CAS :Antibiotics nesoiFormule :C53H83NO14Couleur et forme :White Yellow PowderMasse moléculaire :957.58136Silodosin S-Enantiomer
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C25H32F3N3O4Couleur et forme :White Off-White Crystalline PowderMasse moléculaire :495.23449Bicalutamide Related Compound A (N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluoro-phenyl)sulfinyl]-2-hydroxy-2-methyl-propanamide)
Other aromatic organo-sulfur compounds (excluding pesticides)Couleur et forme :PowderMasse moléculaire :414.38Apixaban Related Compound F (Ethyl 1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate)
CAS :Lactams, nesoiFormule :C22H20N4O6Couleur et forme :Light Brown PowderMasse moléculaire :436.13828Metoprolol Dimer (1,3-Bis[4-(2-methoxyethyl)phenoxy]propan-2-ol)
CAS :Ether-alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives, nesoiFormule :C21H28O5Couleur et forme :Colorless Light Yellow LiquidMasse moléculaire :360.19367Atazanavir S,R,S,S-diastereomer ((3S,8R,9S,12S)-3,12-Bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-2,5,6,10,13-pentaazatetradecanedioic acid dimethyl ester)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C38H52N6O7Couleur et forme :White Off-White SolidMasse moléculaire :704.38975Ambrisentan Related Compound D (2-[(2,2-Diphenylvinyl)oxy]-4,6-dimethylpyrimidine)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C20H18N2OCouleur et forme :Off-White Fine PowderMasse moléculaire :302.14191Atazanavir Sulfate
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C38H52N6O7·H2SO4Couleur et forme :White Pale Yellow PowderMasse moléculaire :802.35713Rotigotine Related Compound G ((S)-6-{Bis[2-(thiophen-2-yl)ethyl]amino}-5,6,7,8-tetrahydronaphthalen-1-ol hydrochloride)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C22H25NOS2·HClCouleur et forme :Off-White SolidMasse moléculaire :419.11443Sunitinib N-Oxide ((Z)-N,N-diethyl-2-(5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamido)ethan-1-amine oxide)
CAS :Lactams, nesoiFormule :C22H27FN4O3Couleur et forme :Yellow Orange SolidMasse moléculaire :414.20672Celecoxib Related Compound B (4-[3-(4-methylphenyl)-5-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide)
CAS :Sulfonamides, nesoiFormule :C17H14F3N3O2SCouleur et forme :White SolidMasse moléculaire :381.07588Mirabegron Related Compound A ((R)-2-[(4-Aminophenethyl)amino]-1-phenylethan-1-ol hydrochloride)
CAS :Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts thereof, nesoiFormule :C16H20N2O·HClCouleur et forme :White PowderMasse moléculaire :292.13424Rivaroxaban Ethyl Carbamate (ethyl (4-(3-oxomorpholino)phenyl)carbamate)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C13H16N2O4Couleur et forme :White Off-White SolidMasse moléculaire :264.11101Sorafenib Isopropyl Carbamate (Isopropyl {4-[2-(methylcarbamoyl)pyridin-4-yl]oxyphenyl}carbamate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C17H19N3O4Couleur et forme :Off-White PowderMasse moléculaire :329.13756Dofetilide Related Compound D (4-{2-[(4-Aminophenethyl)(methyl)amino]ethoxy}aniline)
CAS :Amino-naphthols and other amino-phenols, their ethers and esters, other than those cont more than one kind of oxygen function; salts thereof, nesoiFormule :C17H23N3OCouleur et forme :Off-White PowderMasse moléculaire :285.18411O-Thienylethyl Rotigotine Hydrochloride ((S)-N-propyl-5-(2-(thiophen-2-yl)ethoxy)-N-(2-(thiophen-2-yl)ethyl)-1,2,3,4-tetrahydronaphthalen-2-amine hydrochloride)
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C25H32ClNOS2Couleur et forme :Pale Beige SolidMasse moléculaire :461.16138Bendroflumethiazide
CAS :Sulfonamides used as drugsFormule :C15H14F3N3O4S2Couleur et forme :PowderMasse moléculaire :421.42Argatroban Related Compound B (Ethyl (4R)-1-[N^8-nitro-L-arginyl]-4-methylpiperidine-2-carboxylate dihydrochloride)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C15H28N6O5·2HClCouleur et forme :Off-White PowderMasse moléculaire :444.16547S-Levetiracetam Hydroxybutyramide Analog ((S)-N-(1-amino-1-oxobutan-2-yl)-4-hydroxybutanamide)
CAS :Acyclic amides (including acyclic carbamates) and their derivatives and salts thereof, nesoiFormule :C8H16N2O3Couleur et forme :White Off-White SolidMasse moléculaire :188.11609Rivaroxaban Open Chain Dithiophene Analog ((S)-5-chloro-N-(4-(5-((5-chlorothiophene-2-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)-N-(2-(2-(methylamino)-2-oxoethoxy)ethyl)thiophene-2-carboxamide)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C25H24Cl2N4O6S2Couleur et forme :White Off-White SolidMasse moléculaire :610.051434'-Hydroxycelecoxib (4-(5-(4-(hydroxymethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide)
CAS :Sulfonamides, nesoiFormule :C17H14F3N3O3SCouleur et forme :White Off-White SolidMasse moléculaire :397.0708Ofloxacin
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C18H20FN3O4Couleur et forme :Off-White Pale Yellow PowderMasse moléculaire :361.14378Brivaracetam Related Compound D ((S)-2-[(R)-2-Oxo-4-propylpyrrolidin-1-yl]butanoic acid)
CAS :Lactams, nesoiFormule :C11H19NO3Couleur et forme :White Off-White Fine PowderMasse moléculaire :213.13649Rivaroxaban isomer (4-(4-(((2-(5-chlorothiophen-2-yl)-4,5-dihydrooxazol-5-yl)methyl)amino)phenyl)morpholin-3-one)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C18H18ClN3O3SCouleur et forme :White Off-White SolidMasse moléculaire :391.07574Rivaroxaban Open Oxomorpholine Ring ((S)-5-chloro-N-((3-(4-(2-hydroxy-N-(2-hydroxyethyl)acetamido) phenyl)-2-oxooxazolidin-5-yl)methyl)thiophene-2-carboxamide)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C19H20ClN3O6SCouleur et forme :White Off-White SolidMasse moléculaire :453.07613Oxprenolol Hydrochloride
CAS :Aromatic drugs of amino-alcohols, other than those contg more than one kind of oxygen function, their ethers and esters; salts thereof, nesoiFormule :C15H23NO3·HCICouleur et forme :White PowderMasse moléculaire :405.08009Levetiracetam
CAS :Lactams, nesoiFormule :C8H14N2O2Couleur et forme :White PowderMasse moléculaire :170.10553Topiramate Related Compound A (2,3:4,5-Bis-O-(1-methylethylidene)-β-D-fructopyranose)
CAS :Heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormule :C12H20O6Couleur et forme :White PowderMasse moléculaire :260.12599Carvedilol Related Compound E (2-(2-Methoxyphenoxy)ethyl amine hydrochloride monohydrate)
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C9H13NO2Couleur et forme :Off-White PowderMasse moléculaire :167.09463Imidazole (1H-Imidazole)
CAS :Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure nesoiFormule :C3H4N2Couleur et forme :White Light Yellow Crystalline PowderMasse moléculaire :68.03745Labetalol Cyclohexyl Analog (5-{2-[(4-Cyclohexylbutan-2-yl)amino]-1-hydroxyethyl}-2-hydroxybenzamide hydrochloride)
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C19H30N2O3·HClCouleur et forme :White PowderMasse moléculaire :370.20232Rotigotine Related Compound H ((S)-5-Methoxy-N-propyl-N-[2-(thiophen-2-yl)ethyl]-1,2,3,4-tetrahydronaphthalen-2-amine)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C20H27NOSCouleur et forme :Light Brown LiquidMasse moléculaire :329.18134Clozapine Resolution Mixture
CAS :Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureCouleur et forme :Yellow Crystalline PowderMasse moléculaire :203.09061Fesoterodine Fumarate
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C26H37NO3·C4H4O4Couleur et forme :White Off-White PowderMasse moléculaire :527.2883Rotigotine Hydrochloride ((6S )-6-[Propyl(2-(2-thienyl)ethyl)amino]-5,6,7,8-tetrahydronaphthalen-1-ol hydrochloride)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C19H25NOSHClCouleur et forme :White Off-White PowderMasse moléculaire :315.16569Rotigotine ((S)-6-{Propyl[2-(thiophen-2-yl)ethyl]amino}-5,6,7,8-tetrahydronaphthalen-1-ol)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C19H25NOSCouleur et forme :White Beige PowderMasse moléculaire :315.16569Labetalol Related Compound A (2-Hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzoic acid hydrochloride)
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C19H23NO4·HClCouleur et forme :Off-White SolidMasse moléculaire :365.13939Omeprazole Related Compound E (4-Methoxy-2-[[(RS)-(5-methoxy-1H-benzimidazol-2-yl)sulfinyl]methyl]-3,5-dimethylpyridine 1-oxide)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C17H19N3O4SCouleur et forme :Off-White PowderMasse moléculaire :361.10963Dofetilide Related Compound B (N-Methyl-N-[4-(methylsulfonamido)phenethyl]-2-[4-(methylsulfonamido)phenoxy]ethan-1-amine oxide)
CAS :Sulfonamides, nesoiFormule :C19H27N3O6S2Couleur et forme :Off-White PowderMasse moléculaire :457.13413Ondansetron Related Compound G (3-[(1H-Imidazol-1-yl)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one)
CAS :Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFormule :C17H17N3OCouleur et forme :White PowderMasse moléculaire :279.13716Ambrisentan Related Compound E (4,6-Dimethylpyrimidin-2-ol)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C6H8N2OCouleur et forme :White Off-White Pale Yellow Crystalline PowderMasse moléculaire :124.06366Desiodoamiodarone ((2-butylbenzofuran-3-yl)(4-(2-(diethylamino)ethoxy)phenyl)methanone)
CAS :Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormule :C25H31NO3Couleur et forme :Colorless LiquidMasse moléculaire :393.23039Labetalol Hydrochloride
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C19H24N2O3·HClCouleur et forme :White Off-White Crystalline PowderMasse moléculaire :364.15537Erlotinib Hydrochloride
CAS :Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureFormule :C22H23N3O4·HClCouleur et forme :Pale Yellow PowderMasse moléculaire :429.14553Desimidazoline Sunitinib (5-Formyl-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, excluding aromatic or modified aromaticFormule :C14H23N3O2Couleur et forme :White Off-White PowderMasse moléculaire :265.17903Methylisoindolinedione (2-methylisoindoline-1,3-dione)
CAS :Imides and their derivatives (excluding sacharin), and salts thereofFormule :C9H7NO2Couleur et forme :White Off-White SolidMasse moléculaire :161.04768Aripiprazole 4,4'-dimer (7,7'-((((ethane-1,1-diylbis(2,3-dichloro-4,1-phenylene))bis(piperazine-4,1-diyl))bis(butane-4,1-diyl))bis(oxy))bis(3,4-dihydroquinolin-2(1H)-one)
CAS :Lactams, nesoiFormule :C48H56Cl4N6O4Couleur et forme :White Off-White SolidMasse moléculaire :920.31172Atazanavir Ditertbutyl Analog (tert-butyl 2-((2S,3S)-3-((tert-butoxycarbonyl)amino)-2-hydroxy-4-phenylbutyl)-2-(4-(pyridin-2-yl)benzyl)hydrazine-1-carboxylate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C32H42N4O5Couleur et forme :Off-White SolidMasse moléculaire :562.31552Butylated Hydroxytoluene
CAS :Monophenols, nesoiFormule :C15H24OCouleur et forme :White PowderMasse moléculaire :220.18272Erlotinib Related Compound A (4-(3-{[6,7-Bis(2-methoxyethoxy) quinazolin-4-yl]amino}phenyl)-2-methyl-3-butyn-2-ol hydrochloride)
CAS :Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormule :C25H29N3O5·HClCouleur et forme :Off-White PowderMasse moléculaire :451.21072Oxcarbazepine Related Compound D (10-(10-Oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamido)-5H-dibenzo[b,f]azepine-5-carboxamide)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C30H22N4O3Couleur et forme :Light Yellow Yellow PowderMasse moléculaire :486.16919Levetiracetam Racemic Mixture (1:1 mixture of levetiracetam S-enantiomer-(2S)-2-(2-oxopyrrolidin-1-yl)butanamide and levetiracetam R-enantiomer (2R)-2-(2-oxopyrrolidin-1-yl)butanamide)
CAS :Lactams, nesoiFormule :C8H14N2O2Couleur et forme :White Off-White PowderMasse moléculaire :170.10553Norepinephrine Related Compound E (2-Chloro-1-(3,4-dihydroxyphenyl)ethan-1-one)
CAS :Ketones and quinones, w/not with other oxygen function,and their halogenated,sulfated,nitrated,or nitrosated derivatives, nesoiFormule :C8H7ClO3Couleur et forme :Dark Grey PowderMasse moléculaire :186.00837Brivaracetam Related Compound C ((R)-2-[(R)-2-Oxo-4-propylpyrrolidin-1-yl]butanamide)
CAS :Lactams, nesoiFormule :C11H20N2O2Couleur et forme :White SolidMasse moléculaire :212.15248Paliperidone Related Compound E (3-{2-[4-(6-Fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-7,8-dihydro-4H-pyrido[1,2-a]pyrimidine-4,9(6H)-dione trifluoroacetate)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C23H25FN4O3·C2HF3O2Couleur et forme :Yellow PowderMasse moléculaire :424.19107Apremilast Open Ring 3-acetamide ((S)-3-acetamido-2-((1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)carbamoyl)benzoic acid)
CAS :Other aromatic organo-sulfur compounds (excluding pesticides)Formule :C22H26N2O8SCouleur et forme :Off-White SolidMasse moléculaire :478.14099O-Desmethyl Apremilast ((S)-N-(2-(1-(3-ethoxy-4-hydroxyphenyl)-2-(methylsulfonyl)ethyl)-1,3-dioxoisoindolin-4-yl)acetamide)
CAS :Other aromatic organo-sulfur compounds (excluding pesticides)Formule :C21H22N2O7SCouleur et forme :Pale Yellow SolidMasse moléculaire :446.11477Apremilast Desphthalyl Amine ((S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethan-1-amine)
CAS :Other aromatic organo-sulfur compounds (excluding pesticides)Formule :C12H19NO4SCouleur et forme :White Off-White SolidMasse moléculaire :273.10348Prasugrel Related Compound D (5-[2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-5,6,7,7a-tetrahydrothieno[3,2-c]pyridin-2(4H)-one)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C18H18FNO2SCouleur et forme :Off-White PowderMasse moléculaire :331.10423Gefitinib Related Compound A (7-Methoxy-6-(3-morpholinopropoxy)quinazolin-4(3H)-one)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C16H21N3O4Couleur et forme :White Yellow PowderMasse moléculaire :319.15321N-Nitroso Bupropion Solution (1 mL ) (N-(tert-butyl)-N-(1-(3-chlorophenyl)-1-oxopropan-2-yl) nitrous amide)
CAS :Compounds with other nitrogen function, nesoiFormule :C13H17ClN2O2Couleur et forme :LiquidMasse moléculaire :268.09786Aripiprazole Related Compound G (7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}quinolin-2(1H)-one)
CAS :Lactams, nesoiFormule :C23H25Cl2N3O2Couleur et forme :White Light Yellow Crystalline PowderMasse moléculaire :445.132383-Acetamidophthalic acid (3-acetamidophthalic acid)
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C10H9NO5Couleur et forme :Off-White SolidMasse moléculaire :223.04807Betahistine Hydrochloride
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C8H12N2·2HCICouleur et forme :White Light Yellow Crystalline PowderMasse moléculaire :415.92464Ondansetron Related Compound D (1,2,3,9-Tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one)
CAS :Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFormule :C14H13NOCouleur et forme :White Off-White PowderMasse moléculaire :211.09971Methyl Alcohol
CAS :Methanol (methyl alcohol)Formule :CH4OCouleur et forme :Colorless Clear LiquidMasse moléculaire :32.02621Plerixafor System Suitability Mixture
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiCouleur et forme :White Off-White SolidParoxetine Related Compound G ((+/-)trans-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4''-fluorophenyl-4'-phenyl)piperidine hydrochloride)
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C25H24FNO3·HClCouleur et forme :White Off-White PowderMasse moléculaire :441.92Fluconazole
CAS :Anti-infective agents, nesoiFormule :C13H12F2N6OCouleur et forme :White Off-White PowderMasse moléculaire :306.10407Deschloro Bupropion Hydrochloride (2-(tert-Butylamino)-1-phenylpropan-1-one hydrochloride)
CAS :Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, nesoiFormule :C13H19NO·HClCouleur et forme :White PowderMasse moléculaire :241.12334Hydroxybenzoyl Paliperidone (3-(2-(4-(4-fluoro-2-hydroxybenzoyl)piperidin-1-yl)ethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C23H28FN3O4Couleur et forme :Off-White SolidMasse moléculaire :429.20638Bupropion Hydrochloride Related Compound A (2-(tert-butylamino)-4'-chloropropiophenone hydrochloride)
CAS :Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, nesoiFormule :C13H18ClNO·HClCouleur et forme :White PowderMasse moléculaire :275.08437Paroxetine Related Compound B ((3S,4R)-3-[(Benzodioxol-5-yloxy)methyl]-4-phenylpiperidine hydrochloride)
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C19H21NO3·HClCouleur et forme :White PowderMasse moléculaire :347.844-Chloro Bupropion Hydrochloride (2-(tert-Butylamino)-1-(3,4-dichlorophenyl)propan-1-one hydrochloride)
CAS :Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, nesoiFormule :C13H17Cl2NO·HClCouleur et forme :Off-White PowderMasse moléculaire :273.06872Sucralose
CAS :Compounds containing an unfused furan ring, whether or not hydrogenated, in the structure, nesoiFormule :C12H19Cl3O8Couleur et forme :White Off-White Crystalline PowderMasse moléculaire :396.01455Sildenafil Related Compound A (1-{[3-(6,7-Dihydro-1-methyl-7-oxo-3-isobutyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl}-4-methylpiperazine)
CAS :Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormule :C23H32N6O4SCouleur et forme :White PowderMasse moléculaire :488.22057Desacetyl Apremilast ((S)-4-Amino-2-[1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]isoindoline-1,3-dione)
CAS :Other aromatic organo-sulfur compounds (excluding pesticides)Formule :C20H22N2O6SCouleur et forme :Yellow PowderMasse moléculaire :418.11986Aripiprazole Hydroxydihydroquinolinone Analog (7-hydroxy-3,4-dihydroquinolin-2(1H)-one)
CAS :Lactams, nesoiFormule :C9H9NO2Couleur et forme :White Off-White SolidMasse moléculaire :163.06333Fluconazole Related Compound C (1,1'-(1,3-phenylene)di(1H-1,2,4-triazole))
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C10H8N6Couleur et forme :White PowderMasse moléculaire :212.08104N-Nitroso Bupropion (N-(tert-butyl)-N-(1-(3-chlorophenyl)-1-oxopropan-2-yl) nitrous amide)
CAS :Compounds with other nitrogen function, nesoiFormule :C13H17ClN2O2Couleur et forme :SolidMasse moléculaire :268.09786Ofloxacin Related Compound A (9-Fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C17H18FN3O4Couleur et forme :Light Yellow PowderMasse moléculaire :347.12813Methoxy Carbamazepine (10-Methoxy-5H-dibenz[b,f]azepine-5-carboxamide)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C16H14N2O2Couleur et forme :White Off-White SolidMasse moléculaire :266.10553Bupropion Hydrochloride Related Compound C (1-(3-chlorophenyl)-2-hydroxypropan-1-one)
CAS :Aromatic ketone-alcohols and ketone-aldehydes, nesoiFormule :C9H9O2ClCouleur et forme :LiquidMasse moléculaire :184.02911Bupropion Hydrochloride
CAS :Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, nesoiFormule :C13H18ClNO·HClCouleur et forme :White Off-White PowderMasse moléculaire :239.10769Chloro N-methylthiophene Carboxamide (5-chloro-N-methylthiophene-2-carboxamide)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C6H6ClNOSCouleur et forme :White Off-White SolidMasse moléculaire :174.98586Salmeterol Resolution Check
Aromatic amino-alcohol-phenols, aromatic amino-acid-pheCouleur et forme :PowderBupropion Hydrochloride Related Compound F (1-(3-chlorophenyl)-1-hydroxypropan-2-one)
CAS :Aromatic ketone-alcohols and ketone-aldehydes, nesoiFormule :C9H9ClO2Couleur et forme :Clear Yellow LiquidMasse moléculaire :184.02911Saxagliptin Related Compound A (Saxagliptin pyrazine analog (1aS,4S,6aR,7aS)-6-amino-4-[(1r,3R,5R,7S)-3-hydroxyadamantan-1-yl]-1,1a,4,6a,7,7a-hexahydro-3H-cyclopropa[4,5]pyrrolo[1,2-a]pyrazin-3-one)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, excluding aromatic or modified aromaticFormule :C18H25N3O2Couleur et forme :White Fine PowderMasse moléculaire :315.19468(S)-Glycidyl Phthalimide ((S)-2-(oxiran-2-ylmethyl)isoindoline-1,3-dione)
CAS :Imides and their derivatives (excluding sacharin), and salts thereofFormule :C11H9NO3Couleur et forme :White Off-White SolidMasse moléculaire :203.05824Rivaroxaban N-acyl glycolic acid ((S)-2-(2-(5-chloro-N-(4-(5-((5-chlorothiophene-2-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)thiophene-2-carboxamido)ethoxy)acetic acid)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C24H21Cl2N3O7S2Couleur et forme :Off-White SolidMasse moléculaire :597.01985-Chloro Bupropion Hydrochloride (2-(tert-Butylamino)-1-(3,5-dichlorophenyl)propan-1-one hydrochloride)
CAS :Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, nesoiFormule :C13H17Cl2NO·HClCouleur et forme :White PowderMasse moléculaire :309.0454Rivaroxaban Phthalamide (N1,N2-bis(((S)-2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)phthalamide)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C36H36N6O10Couleur et forme :Off-White SolidMasse moléculaire :712.24929Bupropion Amine Tosylate (2-Amino-1-(3-chloro-phenyl)-1-propanone 4-methylbenzenesulfonate)
CAS :Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, nesoiFormule :C16H18ClNO4SCouleur et forme :White SolidMasse moléculaire :355.06451Ezetimibe
CAS :Lactams, nesoiFormule :C24H21F2NO3Couleur et forme :White PowderMasse moléculaire :409.14895Atazanavir Related Compound A ((S)-2-[(Methoxycarbonyl)amino]-3,3-dimethylbutanoic acid)
CAS :Acyclic amides (including acyclic carbamates) and their derivatives and salts thereof, nesoiFormule :C8H15NO4Couleur et forme :Off-White White Powder ClumpyMasse moléculaire :189.100113-Chlorobenzoic Acid
CAS :Aromatic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacid and their derivatives not elsewhere specified or includedFormule :C7H5ClO2Couleur et forme :White PowderMasse moléculaire :155.99781Fluconazole Related Compound B (2-(4-Fluorophenyl)-1,3-di(1H-1,2,4-triazol-1-yl)-propan-2-ol)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C13H13FN6OCouleur et forme :White PowderMasse moléculaire :288.11349Aleuritic Acid
CAS :Carboxylic acids w/ alcohol function but w/o other oxygen function and their derivatives, nesoiFormule :C16H32O5Couleur et forme :PowderMasse moléculaire :304.22497Bupropion Hydrochloride Related Compound B (2-(tert-butylamino)-3'-bromopropiophenone hydrochloride)
CAS :Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, nesoiFormule :C13H18BrNO·HClCouleur et forme :Off-White PowderMasse moléculaire :319.03385Fluvoxamine Z-isomer Maleate ((Z)-5-methoxy-1-(4-(trifluoromethyl)phenyl)pentan-1-one O-(2-aminoethyl) oxime maleate)
CAS :Aromatic organic derivatives of hydrazine or of hydroxylamineFormule :C15H21F3N2O2·C4H4O4Couleur et forme :White SolidMasse moléculaire :318.15551N-Carbamoyl Oxcarbazepine (N-Carbamoyl-10-oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C16H13N3O3Couleur et forme :White SolidMasse moléculaire :295.095692-Chloro Bupropion Hydrochloride (2-(tert-Butylamino)-1-(2-chlorophenyl)propan-1-one hydrochloride)
CAS :Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, nesoiFormule :C13H18ClNO·HClCouleur et forme :White PowderMasse moléculaire :275.08437Argatroban Related Compound A ((2R,4R)-1-[N8-nitro- N2-(3-methylquinoline-8-sulfonyl)-L-arginyl]-4-methylpiperidine-2-carboxylic acid)
CAS :Sulfonamides, nesoiFormule :C23H31N7O7SCouleur et forme :White PowderMasse moléculaire :549.20057N6-(1-Iminoethyl)-D-lysine ((2R)-2-[(2S)-2-Aminobutanamido]butanamide)
CAS :Acyclic amides (including acyclic carbamates) and their derivatives and salts thereof, nesoiFormule :C8H17N3O2Couleur et forme :White Off-White SolidMasse moléculaire :187.13208Aminophenylmorpholin-2-one (4-(4-aminophenyl)morpholin-2-one)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C10H12N2O2Couleur et forme :Pale Yellow SolidMasse moléculaire :192.08988N-Nitroso Dabigatran Etexilate Solution (1 mL ) (ethyl 3-(2-(((4-(N-((hexyloxy)carbonyl)carbamimidoyl)phenyl)(nitroso)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C34H40N8O6Couleur et forme :Colorless LiquidMasse moléculaire :656.30708Sunitinib Amide (5-[(Z)-(5-Fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide)
CAS :Lactams, nesoiFormule :C16H14FN3O2Couleur et forme :Pale Yellow Yellow PowderMasse moléculaire :299.107Fluconazole Related Compound A (2-[2-fluoro-4-(1H-1,2,4-triazol-1-yl)phenyl]-1,3-bis(1H-1,2,4-triazol-1-yl)-propan-2-ol)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C15H14FN9OCouleur et forme :White PowderMasse moléculaire :355.13053Topiramate
CAS :Sulfonamides used as drugsFormule :C12H21NO8SCouleur et forme :White Off-White Crystalline PowderMasse moléculaire :339.09879Naproxen Related Compound L (1-(6-methoxynaphthalen-2-yl)ethanone)
CAS :Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc not elsewhere specified or includedFormule :C13H12O2Couleur et forme :White Crystalline PowderMasse moléculaire :200.08373Rivaroxaban Related Compound H ((S)-4,5-Dichloro-N-({2-oxo-3-[4-(3-oxomorpholino)phenyl]oxazolidin-5-yl}methyl)thiophene-2-carboxamide)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C19H17Cl2N3O5SCouleur et forme :Yellow PowderMasse moléculaire :469.0266Gefitinib Related Compound B (N-(4-Chloro-3-fluorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C22H24ClFN4O3Couleur et forme :Light Yellow PowderMasse moléculaire :446.1521Metoprolol Related Compound A ((+/-)1-(ethylamino)-3-[4-(2-methoxyethyl)phenoxy]-propan-2-ol)
CAS :Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts therof, nesoiFormule :C14H23NO3Couleur et forme :White Clumpy PowderMasse moléculaire :253.16779Deoxy Salmeterol (4-(1-hydroxy-2-((6-(4-phenylbutoxy)hexyl)amino)ethyl)-2-methylphenol)
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C25H37NO3Couleur et forme :White Off-White SolidMasse moléculaire :399.27734Polyvinyl Alcohol
CAS :Polyvinyl alcohols, whether or not containing unhydrolyzed acetate groupsFormule :H(C2H4O)m(C4H6O2)nHCouleur et forme :PowderMasse moléculaire :46.0684Rotigotine Hydrochloride Ethyl Analog ((S)-6-(ethyl(2-(thiophen-2-yl)ethyl)amino)-5,6,7,8-tetrahydronaphthalen-1-ol hydrochloride)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C18H24ClNOSCouleur et forme :Beige SolidMasse moléculaire :337.12671Gefitinib
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C22H24ClFN4O3Couleur et forme :White PowderMasse moléculaire :446.1521Copovidone
CAS :Vinyl copolymers in primary forms, nesoiFormule :(C6H9NO)n(C4H6O2)mCouleur et forme :White Yellow PowderMasse moléculaire :197.23 g/molBrivaracetam Related Compound A ((S)-2-[(S)-2-Oxo-4-propylpyrrolidin-1-yl]butanamide)
CAS :Lactams, nesoiFormule :C11H20N2O2Couleur et forme :White PowderMasse moléculaire :212.15248Regular Bleached Shellac
CAS :Natural gums, gum resins, resins and balsams nesoiCouleur et forme :PowderMetoprolol Succinate
CAS :Aromatic drugs of amino-alcohols, other than those contg > one kind of oxygen function, their ethers and esters; salts thereof, nesoiFormule :(C15H25NO3)2·C4H6O4Couleur et forme :White Off-White PowderMasse moléculaire :534.36689Desethylamiodarone (2-Butyl-3-benzofuranyl-4-[2-(ethylamino)ethoxy]-3,5-diiodophenyl Ketone Hydrochloride)
CAS :Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormule :C23H25I2NO3·HClCouleur et forme :White Off-White SolidMasse moléculaire :652.96907Rivaroxaban Related Compound G ((S)-2-({2-oxo-3-[4-(3-oxomorpholino)phenyl]oxazolidin-5-yl}methyl)isoindoline-1,3-dione)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C22H19N3O6Couleur et forme :White Off-White SolidMasse moléculaire :421.12739Amiodarone Related Compound D ((2-Butylbenzofuran-3-yl)(4-hydroxy-3,5-diiodophenyl)methanone)
CAS :Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormule :C19H16I2O3Couleur et forme :White Yellow PowderMasse moléculaire :545.918894-(Pyridin-2-yl)benzaldehyde (4-(Pyridin-2-yl)benzaldehyde)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C12H9NOCouleur et forme :Pale Yellow Off-White PowderMasse moléculaire :183.06841Paroxetine Related Compound E (4-(4-Fluorophenyl)-1-methyl-1,2,3,6-tetrahydropyridine hydrochloride)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C12H14FN·HClCouleur et forme :White PowderMasse moléculaire :191.11103O-Desmethylmetoprolol (1-(4-(2-hydroxyethyl)phenoxy)-3-(isopropylamino)propan-2-ol)
CAS :Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts thereof, nesoiFormule :C14H23NO3Couleur et forme :White Off-White SolidMasse moléculaire :253.16779Fluconazole Diol (2-(2,4-Difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)propane-1,2-diol)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C11H11F2N3O2Couleur et forme :White SolidMasse moléculaire :255.08193Ambrisentan Related Compound B (2-Hydroxy-3-methoxy-3,3-diphenylpropanoic acid)
CAS :Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc, nesoiFormule :C16H16O4Couleur et forme :Off-White PowderMasse moléculaire :272.10486
![Omeprazole Related Compound I (4-Methoxy-2-[[(5-methoxy-1H-benzimidazol-2-yl)sulfonyl]methyl]-3,5-…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1478561.webp&w=3840&q=75)
![Celecoxib Related Compound B (4-[3-(4-methylphenyl)-5-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesul…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1098526.webp&w=3840&q=75)
